229 related articles for article (PubMed ID: 29341392)
1. Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease.
Adejumo AC; Ajayi TO; Adegbala OM; Adejumo KL; Alliu S; Akinjero AM; Onyeakusi NE; Ojelabi O; Bukong TN
Liver Int; 2018 Aug; 38(8):1475-1486. PubMed ID: 29341392
[TBL] [Abstract][Full Text] [Related]
2. Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis.
Adejumo AC; Adegbala OM; Adejumo KL; Bukong TN
Can J Gastroenterol Hepatol; 2018; 2018():9430953. PubMed ID: 30345261
[TBL] [Abstract][Full Text] [Related]
3. Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study.
Adejumo AC; Alliu S; Ajayi TO; Adejumo KL; Adegbala OM; Onyeakusi NE; Akinjero AM; Durojaiye M; Bukong TN
PLoS One; 2017; 12(4):e0176416. PubMed ID: 28441459
[TBL] [Abstract][Full Text] [Related]
4. Reduced Risk of Alcohol-Induced Pancreatitis With Cannabis Use.
Adejumo AC; Akanbi O; Adejumo KL; Bukong TN
Alcohol Clin Exp Res; 2019 Feb; 43(2):277-286. PubMed ID: 30570765
[TBL] [Abstract][Full Text] [Related]
5. National survey of alcoholic liver disease in Japan (1968-91).
Takada A; Tsutsumi M
J Gastroenterol Hepatol; 1995; 10(5):509-16. PubMed ID: 8963025
[TBL] [Abstract][Full Text] [Related]
6. Reduced Prevalence of Alcoholic Gastritis in Hospitalized Individuals Who Consume Cannabis.
Adejumo AC; Li J; Akanbi O; Adejumo KL; Bukong TN
Alcohol Clin Exp Res; 2019 Feb; 43(2):270-276. PubMed ID: 30536396
[TBL] [Abstract][Full Text] [Related]
7. National survey of hepatocellular carcinoma in heavy drinkers in Japan.
Horie Y; Yamagishi Y; Kajihara M; Kato S; Ishii H
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):32S-36S. PubMed ID: 12960504
[TBL] [Abstract][Full Text] [Related]
8. Current Status of Alcoholic Liver Disease in Japan and Therapeutic Strategy.
Horie Y; Ebinuma H; Kikuchi M; Lamao Takanori
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2016 Aug; 51(2):71-90. PubMed ID: 30462383
[TBL] [Abstract][Full Text] [Related]
9. Alcoholic Liver Disease Epidemiology in the United States: A Retrospective Analysis of 3 US Databases.
Dang K; Hirode G; Singal AK; Sundaram V; Wong RJ
Am J Gastroenterol; 2020 Jan; 115(1):96-104. PubMed ID: 31517639
[TBL] [Abstract][Full Text] [Related]
10. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.
Younossi ZM; Otgonsuren M; Henry L; Venkatesan C; Mishra A; Erario M; Hunt S
Hepatology; 2015 Dec; 62(6):1723-30. PubMed ID: 26274335
[TBL] [Abstract][Full Text] [Related]
11. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
12. Prediction of future hepatocellular carcinoma incidence in moderate to heavy alcohol drinkers with the FIB-4 liver fibrosis index.
Suh B; Yun JM; Park S; Shin DW; Lee TH; Yang HK; Ahn E; Lee H; Park JH; Cho B
Cancer; 2015 Nov; 121(21):3818-25. PubMed ID: 26178294
[TBL] [Abstract][Full Text] [Related]
13. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
Horie Y; Yamagishi Y; Ishii H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
[TBL] [Abstract][Full Text] [Related]
14. [National survey of alcoholic liver disease in Japan].
Horie Y; Ishii H; Hibi T
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Dec; 39(6):505-10. PubMed ID: 15675363
[TBL] [Abstract][Full Text] [Related]
15. Cannabis use predicts risks of heart failure and cerebrovascular accidents: results from the National Inpatient Sample.
Kalla A; Krishnamoorthy PM; Gopalakrishnan A; Figueredo VM
J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):480-484. PubMed ID: 29879084
[TBL] [Abstract][Full Text] [Related]
16. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
[TBL] [Abstract][Full Text] [Related]
17. Rising Trends in Hospitalizations for Cardiovascular Events among Young Cannabis Users (18-39 Years) without Other Substance Abuse.
Desai R; Fong HK; Shah K; Kaur VP; Savani S; Gangani K; Damarlapally N; Goyal H
Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31387198
[No Abstract] [Full Text] [Related]
18. Cancer incidence among alcoholic liver disease patients in Finland: A retrospective registry study during years 1996-2013.
Sahlman P; Nissinen M; Pukkala E; Färkkilä M
Int J Cancer; 2016 Jun; 138(11):2616-21. PubMed ID: 26756434
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Alcohol-Associated Liver Disease.
Han S; Yang Z; Zhang T; Ma J; Chandler K; Liangpunsakul S
Clin Liver Dis; 2021 Aug; 25(3):483-492. PubMed ID: 34229835
[TBL] [Abstract][Full Text] [Related]
20. Relationship Between Frequent Recreational Cannabis (Marijuana and Hashish) Use and Periodontitis in Adults in the United States: National Health and Nutrition Examination Survey 2011 to 2012.
Shariff JA; Ahluwalia KP; Papapanou PN
J Periodontol; 2017 Mar; 88(3):273-280. PubMed ID: 27718772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
